The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Drug effects on the thyroid.
Abstract
The list of medications, many commonly used, that adversely affect thyroid function or the interpretation of standard thyroid tests is growing. This review addresses drug-induced thyroid dysfunction, emphasizing clinically relevant interactions and laboratory assay artifacts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Drug-induced hypothyroidism is caused by medications such as amiodarone, lithium, and immune checkpoint inhibitors ( Figure 1 ). 28,29”
From Hypothyroidism: A Review (2025) · cites this paper as [28]
In the citing paper
“while biotin may interfere with some T4 assay systems (79, 80).”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [79]
In the citing paper
“A number of drugs, such as phenytoin, carbamazepine, salsalate, salicylate, furosemide, diclofenac, ethacrynic acid, and heparin, have been observed in vitro to displace T4 from the distribution proteins, changing the amount of thyroxine bound to plasma protein”
From ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism (2025) · cites this paper as [79]
In the citing paper
“Some of these drugs may also directly interfere with components and principles used for the hormone assays.136”
In the citing paper
“A number of medications can affect the thyroid function tests not only by interfering with the synthesis, transport, and metabolism of TSH and thyroid hormones but also by interfering with thyroid function immunoassays (30, 37–40) ( Table 1 ).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [37]
In the citing paper
“On the other hand, retinoids, mitotane and several drugs modulating the immune system and used for antineoplastic purpose may result in hypophysitis and cause clinically significant central hypothyroidism (Burch, 2019;Feldt-Rasmussen and Klose 2020;Feldt-Rasmussen and Rasmussen, 2018), as may head trauma including those related to sport and blast injuries (Benvenga et al., 2018).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Burch, 2019
In the citing paper
“Fortunately, most of these medications do not cause clinically evident central hypothyroidism.”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Burch, 2019
In the citing paper
“A number of other medications and drugs of abuse reportedly increase TBG levels: selective oestrogen receptor modulators, tamoxifen, heroin, methadone, 5-fluorouracil, and mitotane [ 88 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
In the citing paper
“Firstly, therapeutic levels of phenytoin, carbamazepine, salsalate, salicylate, furosemide, fenclofenac, ethacrynic acid, and heparin induce the displacement of T4 from the binding proteins in vitro [ 87 , 88 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
In the citing paper
“Conversely, exposure to glucocorticoids, niacin, and androgens leads to a fall in TBG levels and thus a decrease in the LT4 requirement [ 88 , 92 ].”
From Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults (2022) · cites this paper as [88]
Citations
Cites
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Oudard, S. M., Négrier, S., Szczylik, C. A., Пили, Р., Bjarnason, G. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1293 · Cited by 2,182
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Cella, D. F., Reeves, J. A., Hawkins, R. E., Guo, J., Nathan, P., Staehler, M. D., SOUZA, P. D., Merchan, J. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303989 · Cited by 1,928
Mechanisms of thyroid hormone action
Brent, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60047 · Cited by 1,244
Barroso-Sousa, R., Barry, W. T., Garrido-Castro, A. C., Hodi, F. S., Min, L., Krop, I. E., & Tolaney, S. M. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3064 · Cited by 1,115
Lithium toxicity profile: a systematic review and meta-analysis
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61516-x · Cited by 881
Bertrand, A., Kostine, M., Barnetche, T., Truchetet, M.-E., & Schaeverbeke, T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0455-8 · Cited by 704
Osorio, J. C., Ni, A., Chaft, J. E., Pollina, R., Kasler, M. K., Stephens, D., Rodriguez, C., Cambridge, L., Rizvi, H., Wolchok, J. D., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw640 · Cited by 659
Trends in dietary supplement use among US adults from 1999-2012.
Kantor, E. D., Rehm, C. D., Du, M., White, E., & Giovannucci, E. L. (2016) · JAMA · doi:10.1001/jama.2016.14403 · Cited by 644
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, L., Barroso‐Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 550
Ryder, M., Callahan, M., Postow, M. A., Wolchok, J., & Fagin, J. A. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0499 · Cited by 439
Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
Corsello, S. M., Barnabei, A., Marchetti, P., De Vecchis, L., Salvatori, R., & Torino, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4075 · Cited by 403
Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors
Desai, J., Yassa, L., Marqusee, E., George, S., Frates, M. C., Chen, M. H., Morgan, J. A., Dychter, S. S., Larsen, P. R., Demetri, G. D., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-9-200611070-00008 · Cited by 402
Basaria, S. S., & Cooper, D. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.11.028 · Cited by 341
Thyroxine in Goiter, Helicobacter pylori Infection, and Chronic Gastritis
Centanni, M., Gargano, L., Canettieri, G., Viceconti, N., Franchi, A., Fave, G. D., & Annibale, B. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa043903 · Cited by 329
Central hypothyroidism associated with retinoid X receptor-selective ligands
Sherman, S. I., Gopal, J., Haugen, B. R., Chiu, A. C., Whaley, K., Nowlakha, P., & Duvic, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401404 · Cited by 315
Increased need for thyroxine in women with hypothyroidism during estrogen therapy
Arafah, B. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442302 · Cited by 267
Bartalena, L., Bogazzi, F., Chiovato, L., Hubalewska-Dydejczyk, A., Links, T. P., & Vanderpump, M. (2018) · European Thyroid Journal · doi:10.1159/000486957 · Cited by 264
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm
Favresse, J., Burlacu, M.-C., Maiter, D., & Gruson, D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00119 · Cited by 258
Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab
de Filette, J., Jansen, Y., Schreuer, M., Everaert, H., Velkeniers, B., Neyns, B., & Bravenboer, B. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2300 · Cited by 244
Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
Baker, D., Herrod, S. S., Álvarez-González, C., Giovannoni, G., & Schmierer, K. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0676 · Cited by 242
Immune-Related Thyroiditis with Immune Checkpoint Inhibitors
Iyer, P. C., Cabanillas, M. E., Waguespack, S. G., Hu, M. I., Thosani, S., Lavis, V. R., Busaidy, N. L., Subudhi, S. K., Diab, A., & Dadu, R. (2018) · Thyroid · doi:10.1089/thy.2018.0116 · Cited by 238
Lazarus, J. H. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.002 · Cited by 230
The Effect of Hepatic Enzyme-Inducing Drugs on Thyroid Hormones and the Thyroid Gland*
CURRAN, P. G., & DEGROOT, L. J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-135 · Cited by 226
The classic pathways of thyroid hormone metabolism
van der Spek, A. H., Fliers, E., & Boelen, A. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.025 · Cited by 194
Morganstein, D. L., Lai, Z., Spain, L., Diem, S., Levine, D., Mace, C., Gore, M., & Larkin, J. (2017) · Clinical Endocrinology · doi:10.1111/cen.13297 · Cited by 190
Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study
Yamauchi, I., Sakane, Y., Fukuda, Y., Fujii, T., Taura, D., Hirata, M., Hirota, K., Ueda, Y., Kanai, Y., Yamashita, Y., et al. (2017) · Thyroid · doi:10.1089/thy.2016.0562 · Cited by 169
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
Daffara, F., De Francia, S., Reimondo, G., Zaggia, B., Aroasio, E., Porpiglia, F., Volante, M., Termine, A., Di Carlo, F., Dogliotti, L., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0103 · Cited by 167
Gastrointestinal malabsorption of thyroxine
Virili, C., Antonelli, A., Santaguida, M. G., Benvenga, S., & Centanni, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00168 · Cited by 164
Iodine-induced thyroid dysfunction
Leung, A. M., & Braverman, L. E. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283565bb2 · Cited by 161
Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy
Lee, H., Hodi, F. S., Giobbie-Hurder, A., Ott, P. A., Buchbinder, E. I., Haq, R., Tolaney, S., Barroso-Sousa, R., Zhang, K., Donahue, H., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0208 · Cited by 161
Kimbara, S., Fujiwara, Y., Iwama, S., Ohashi, K., Kuchiba, A., Arima, H., Yamazaki, N., Kitano, S., Yamamoto, N., & Ohe, Y. (2018) · Cancer Science · doi:10.1111/cas.13800 · Cited by 158
Daniels, G. H., Vladic, A., Brinar, V., Zavalishin, I., Valente, W., Oyuela, P., Palmer, J., & Margolin, D. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2201 · Cited by 150
Chen, F., Day, S. L., Metcalfe, R. A., Sethi, G., Kapembwa, M. S., Brook, M. G., Churchill, D., de Ruiter, A., Robinson, S., Lacey, C. J., et al. (2005) · Medicine · doi:10.1097/01.md.0000159082.45703.90 · Cited by 142
Scott, E. S., Long, G. V., Guminski, A., Clifton-Bligh, R. J., Menzies, A. M., & Tsang, V. H. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0810 · Cited by 142
Central hypothyroidism — a neglected thyroid disorder
Beck-Peccoz, P., Rodari, G., Giavoli, C., & Lania, A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.47 · Cited by 140
Localization of human thyroxine absorption
HAYS, M. T. (1991) · Thyroid · doi:10.1089/thy.1991.1.241 · Cited by 138
Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults
Li, D., Radulescu, A., Shrestha, R. T., Root, M., Karger, A. B., Killeen, A. A., Hodges, J. S., Fan, S.-L., Ferguson, A. M., Garg, U. C., et al. (2017) · JAMA · doi:10.1001/jama.2017.13705 · Cited by 132
Phase II study of alemtuzumab in chronic lymphoproliferative disorders
Ferrajoli, A., O'Brien, S. M., Cortes, J. E., Giles, F. J., Thomas, D. A., Faderl, S. H., Kurzrock, R., Lerner, S. A., Kontoyiannis, D. P., & Keating, M. J. (2003) · Cancer · doi:10.1002/cncr.11551 · Cited by 127
Elston, M. S., Sehgal, S., Toit, S. D., Yarndley, T., & Conaglen, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1971 · Cited by 127
Biotin Treatment Mimicking Graves’ Disease
Kummer, S., Hermsen, D. F., & Distelmaier, F. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1602096 · Cited by 120
Biotin Interference with Routine Clinical Immunoassays: Understand the Causes and Mitigate the Risks
Samarasinghe, S., Meah, F. A., Singh, V., Basit, A., Emanuele, N., Emanuele, M. A., Mazhari, A., & HOLMES, E. W. (2017) · Endocrine Practice · doi:10.4158/ep171761.ra · Cited by 115
Association between lithium use and thyrotoxicosis caused by silent thyroiditis
Miller, K. K., & Daniels, G. H. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01381.x · Cited by 114
Sachmechi, I., Reich, D. M., Aninyei, M., Wibowo, F., Gupta, G., & Kim, P. J. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.345 · Cited by 112
Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination
Abdulrahman, R. M., Verloop, H., Hoftijzer, H., Verburg, E., Hovens, G. C., Corssmit, E. P., Reiners, C., Gelderblom, H., Pereira, A. M., Kapiteijn, E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2507 · Cited by 112
Surks, M. (1996) · JAMA · doi:10.1001/jama.275.19.1495 · Cited by 110
Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies
Lupoli, R., Di Minno, A., Tortora, A., Ambrosino, P., Arianna Lupoli, G., & Di Minno, M. N. D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2965 · Cited by 102
Shifren, J. L., & Avis, N. E. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318032c505 · Cited by 101
Vita, R., Saraceno, G., Trimarchi, F., & Benvenga, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2684 · Cited by 99
Mechanism of the Heparin-Induced Increase in the Concentration of Free Thyroxine in Plasma*
Mendel, C. M., Frost, P. H., Kunitake, S. T., & Cavalieri, R. R. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1259 · Cited by 98
ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: Thyroid effects of tyrosine kinase inhibitors
Illouz, F., Braun, D., Briet, C., Schweizer, U., & Rodien, P. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0198 · Cited by 97
Krouse, R. S., Royal, R. E., Heywood, G., Weintraub, B. D., White, D. E., Steinberg, S. M., Rosenberg, S. A., & Schwartzentruber, D. J. (1995) · Journal of Immunotherapy · doi:10.1097/00002371-199511000-00008 · Cited by 94
Influence of Thyroid Dysfunction on Drug Pharmacokinetics
Shenfield, G. M. (1981) · Clinical Pharmacokinetics · doi:10.2165/00003088-198106040-00003 · Cited by 93
Perrild, H., Hegedűs, L. D., Baastrup, P. C., Kayser, L., & Kastberg, S. E. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.11.1518 · Cited by 87
McMillen, B., Dhillon, M. S., & Yong-Yow, S. (2016) · BMJ Case Reports · doi:10.1136/bcr-2016-214603 · Cited by 87
Wijeratne, N. G., Doery, J. C. G., & Lu, Z. X. (2012) · Pathology · doi:10.1097/pat.0b013e32835a3c17 · Cited by 84
Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features
Pariani, N., Willis, M., Muller, I., Healy, S., Nasser, T., McGowan, A., Lyons, G., Jones, J., Chatterjee, K., Dayan, C., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00359 · Cited by 84
Complex Drug-Drug-Disease Interactions Between Amiodarone, Warfarin, and the Thyroid Gland
Kurnik, D., Loebstein, R., Farfel, Z., Ezra, ., Halkin, H., & Olchovsky, D. (2004) · Medicine · doi:10.1097/01.md.0000123095.65294.34 · Cited by 83
Adjunctive cholestyramine therapy for thyrotoxicosis*
Solomon, B. L., Wartofsky, L., & Burman, K. D. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00970.x · Cited by 83
Misleading serum free thyroxine results during low molecular weight heparin treatment
Stevenson, H. P., Pooler, G., Archbold, R., Johnston, P. B., Young, I. S., & Sheridan, B. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.5.1002 · Cited by 77
Smit, J. W. A., Stokkel, M. P. M., Pereira, A. M., Romijn, J. A., & Visser, T. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2822 · Cited by 59
Lorenzi, A. R., Clarke-Cornwell, A. M., Wooldridge, T., Waldmann, H., Hale, G., Symmons, D. P. M., Hazleman, B. L., & Isaacs, J. D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23122 · Cited by 46
The Use of Bile Acid Sequestrants to Lower Serum Thyroid Hormones in Iatrogenic Hyperthyroidism
Shakir, K. M. M., Michaels, R. D., Hays, J. H., & Potter, B. B. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-2-199301150-00006 · Cited by 45
Brilli, L., Danielli, R., Ciuoli, C., Calabrò, L., Giacomo, A. M. D., Cerase, A., Paffetti, P., Sestini, F., Porcelli, B., Maio, M., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1289-2 · Cited by 45
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism
Russo, M., Scollo, C., Pellegriti, G., Cotta, O. R., Squatrito, S., Frasca, F., Cannavò, S., & Gullo, D. (2016) · Clinical Endocrinology · doi:10.1111/cen.12868 · Cited by 36
Kraszewska, A., Chlopocka‐Wozniak, M., Abramowicz, M. J., Sowiński, J., & RYBAKOWSKI, J. K. (2014) · Bipolar Disorders · doi:10.1111/bdi.12275 · Cited by 34
Kruit, W. H. J., Bolhuis, R. L. H., Goey, S. H., Jansen, R. L. H., Eggermont, A. M. M., Batchelor, D., Schmitz, P. I. M., & Stoter, G. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.5.921 · Cited by 30
Figge, J., & Dluhy, R. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-7-553 · Cited by 30
Abnormal Thyroid Function Test Results in Patients Taking Salsalate
McConnell, R. (1992) · JAMA · doi:10.1001/jama.1992.03480090090033 · Cited by 27
Two Cases of Statin-Induced Myopathy Caused By Induced Hypothyroidism
Lando, H. M., & Burman, K. D. (2008) · Endocrine Practice · doi:10.4158/ep.14.6.726 · Cited by 18
Mammen, J. S., Ghazarian, S. R., Pulkstenis, E., Subramanian, G. M., Rosen, A., & Ladenson, P. W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1026 · Cited by 16
Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication
Kim, H. I., Kim, T. H., Kim, H., Kim, Y. N., Jang, H. W., Chung, J. H., Moon, S. M., Jhun, B. W., Lee, H., Koh, W.-J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169775 · Cited by 16
A Single 10 mg Oral Dose of Biotin Interferes with Thyroid Function Tests
Biscolla, R. P. M., Chiamolera, M. I., Kanashiro, I., Maciel, R. M. B., & Vieira, J. G. H. (2017) · Thyroid · doi:10.1089/thy.2016.0623 · Cited by 14
Life‐Threatening Thyrotoxicosis
Warnock, A., Cooper, D. S., & Burch, H. B. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch16 · Cited by 13
Hypothyroidism Misdiagnosed as Statin Intolerance
Krieger, E. V., & Knopp, R. H. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-1-200907070-00018 · Cited by 9
Research works printed but not linked: 4
- Kopp P, 2013, In: Braverman LE, Cooper DS, eds. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 10th ed, 48
- Duvic M, 2001, Arch Dermatol, 137, 581
- Martino E, 2001, Endocr Rev, 22, 240
- 10.1001/jama.1996.03530430039036 · DOI · Paper page
Cited by
Sorted by citations
Chaker, L., Razvi, S., Bensenor, I. M., Azizi, F., Pearce, E. N., & Peeters, R. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00357-7 · Cited by 330
Feldt-Rasmussen, U., Effraimidis, G., & Klose, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111173 · Cited by 170
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease
Saevarsdottir, S., Olafsdottir, T. A., Ivarsdottir, E. V., Halldorsson, G. H., Gunnarsdottir, K., Sigurdsson, A., Johannesson, A., Sigurdsson, J. K., Juliusdottir, T., Lund, S. H., et al. (2020) · Nature · doi:10.1038/s41586-020-2436-0 · Cited by 137
Thyroid Hormone Plays an Important Role in Cardiac Function: From Bench to Bedside
Yamakawa, H., Kato, T., Noh, J. Y., Yuasa, S., Kawamura, A., Fukuda, K., & Aizawa, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.606931 · Cited by 137
Euthyroid Sick Syndrome in Patients With COVID-19
Zou, R., Wu, C., Zhang, S., Wang, G., Zhang, Q., Yu, B., Wu, Y., Dong, H., Wu, G., Wu, S., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.566439 · Cited by 117
Metadata
- Authors
- Burch, H. B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Burch, Henry B.
- ORCID
- Burch, Henry B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-08-22
- Volume
- 381
- Issue
- 8
- Pages
- 749-761
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2969848078
- Cited by
- 164
- References
- 78
- Citations by year
- 2026: 22 · 2025: 20 · 2024: 20 · 2023: 23 · 2022: 25 · 2021: 23 · 2020: 26 · 2019: 3
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- drug-induced thyroid dysfunction, thyroid function tests, drug interactions, adverse drug reactions, thyroid hormones
- MeSH terms
- Pharmaceutical Preparations, Humans, Thyroid Gland, Thyroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
